Japan commits $800 million to the Global Fund

20 May 2016
globalfund-big

The government of Japan announced today a pledge of $800 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria for the Fifth Replenishment that starts in 2017, representing a 46% increase when measured in Japanese yen, due to fluctuating exchange rates.

Coming just before Japan’s hosting of the G7 Summit in Ise-Shima on May 26-27, the commitment signals Japan’s steadfast leadership in global health.Prime Minister Shinzo Abe announced Japan’s intention to contribute to respond to public health emergencies, to control infectious diseases and to achieve the Universal Health Coverage.

The Global Fund expressed deep gratitude to the people and the Government of Japan."Japan has been an unwavering supporter of the Global Fund since we began, providing both financial and intellectual leadership to our partnership," said Mark Dybul, executive director of the Global Fund, adding: "Prime Minister Abe's commitment to ending these epidemics and promoting access to basic health services and universal health coverage is a great example leadership in global health.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical